SCHEMBL7659352

SCHEMBL7659352

C[C@@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 9/20 0.55
PGR P06401 3/20 0.53
MAPT P10636 2/20 0.53
NR1I2 O75469 1/20 0.53
NR3C1 P04150 1/20 0.53
ADRB1 P08588 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CNR1 P21554 1/20 0.53
SLC6A2 P23975 1/20 0.53
HTR2A P28223 1/20 0.53
HTR2C P28335 1/20 0.53
MAPK1 P28482 1/20 0.53
AGTR1 P30556 1/20 0.53
CCKBR P32239 1/20 0.53
PPARG P37231 1/20 0.53
OPRK1 P41145 1/20 0.53
SLC6A3 Q01959 1/20 0.53
PDE4D Q08499 1/20 0.53
PDE3A Q14432 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1153025 0.88 CYP46A1 (0.72) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1153331 0.86 CYP46A1 (0.51) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1152578 0.84 CYP46A1 (0.51) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL2625353 0.82 CYP46A1 (0.77) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1702633 0.82 CYP46A1 (0.77) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1702634 0.82 CYP46A1 (0.77) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1152275 0.80 CYP46A1 (0.50) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1153338 0.76 CYP46A1 (0.45) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1153878 0.75 CYP46A1 (0.66) CYP46A1PGRMAPTNR1I2NR3C1
SCHEMBL1151743 0.75 CYP46A1 (0.66) CYP46A1PGRMAPTNR1I2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489320-B1 NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND BENZOXAPINONE FOR TREATMENT OF HIV INFECTION BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-12-03 US claimed
US-6489320-B1 NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND BENZOXAPINONE FOR TREATMENT OF HIV INFECTION BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-12-03 US disclosed
US-6140320-A FOR TREATING HIV(HUMAN IMMUNODEFICIENCY VIRUS) INFECTIONS DUPONT PHARMACEUTICALS COMPANY (US) 2000-10-31 US disclosed